Current thoughts on the phosphatidylinositol transfer protein family  by Allen-Baume, Victoria et al.
Minireview
Current thoughts on the phosphatidylinositol transfer protein family
Victoria Allen-Baume, Bruno Se¤gui, Shamshad Cockcroft
Department of Physiology, University College London, London WC1E 6JJ, UK
Received 1 July 2002; revised 27 August 2002; accepted 6 September 2002
First published online 19 September 2002
Edited by Edward A. Dennis, Isabel Varela-Nieto and Alicia Alonso
Abstract Monomeric transport of lipids is carried out by a
class of proteins that can shield a lipid from the aqueous envi-
ronment by binding the lipid in a hydrophobic cavity. One such
group of proteins is the phosphatidylinositol transfer proteins
(PITP) that can bind phosphatidylinositol and phosphatidylcho-
line and transfer them from one membrane compartment to
another. PITPs are found in both unicellular and multicellular
organisms but not bacteria. In mice and humans, the PITP
domain responsible for lipid transfer is found in ¢ve proteins,
which can be classi¢ed into two classes based on sequence. Class
I PITPs comprises two family members, K and L, small 35 kDa
proteins with a single PITP domain which are ubiquitously ex-
pressed. Class IIA PITPs (RdgBKI and II) are larger proteins
possessing additional domains that target the protein to mem-
branes and are only able to bind lipids but not mediate transfer.
Finally, Class IIB PITP (RdgBL) is similar to Class I in size
(38 kDa) and is also ubiquitously expressed. Class III PITPs,
exempli¢ed by the Sec14p family, are found in yeast and plants
but are unrelated in sequence and structure to Class I and Class
II PITPs. In this review we discuss whether PITP proteins are
passive transporters or are regulated proteins that are able to
couple their transport and binding properties to speci¢c biolog-
ical functions including inositol lipid signalling and membrane
turnover.
1 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
Key words: Phospholipase C; Phosphatidylinositol 3-kinase;
Phosphoinositide; Membrane tra⁄c; Growth factor;
Lipid signaling
1. Introduction
Eukaryotic phosphatidylinositol transfer proteins (PITPs)
are ubiquitous proteins that transport phosphatidylinositol
(PI) or phosphatidylcholine (PC) between membranes and
participate in cellular phosphoinositide metabolism during
signal transduction and vesicular tra⁄cking [1^3]. PITPs
were ¢rst puri¢ed on the basis of their transfer activity to-
wards PI [4] and subsequent studies have implicated PITP in
delivering PI to speci¢c cellular compartments, where PI can
be further phosphorylated by speci¢c lipid kinases [5^12]. This
function of PITP depends on its ability to bind a single PI or
PC molecule. PITPK has an internal cavity that can sequester
the entire lipid within the body of the protein and therefore
facilitate transport through the hostile aqueous environment
[13]. The ability to transport hydrophobic ligands is not
unique to PITPs and is shared by many other proteins. PI/
PC transfer can also be mediated by Sec14p (also known as
yeast PITP), a protein ¢rst identi¢ed in Saccharomyces cere-
visiae [14]. However, Sec14p is unrelated to PITP proteins in
both sequence and structure [13,15]. PC transfer can also be
mediated by the START domain found in PC transfer protein
(PC-TP), a 28 kDa protein [16^18]. PITP, PC-TP and Sec14p
are examples of proteins that mainly comprise a single domain
that can sequester a hydrophobic ligand in a cavity and so is
able to mediate the movement of the ligand through the aque-
ous phase. With the completion of the sequencing of genomes
of several organisms, it is increasingly clear that these do-
mains are not only found in proteins, comprising a single
domain, but can be present in larger proteins with several
other domains.
2. Proteins containing the PITP domain
Table 1 provides a summary of PITP proteins identi¢ed in
various organisms (by sequence only in some cases) and the
proteins have been classi¢ed by sequence similarity. The best
studied PITPs are the mammalian Class I PITPs, comprising
PITPK and PITPL which are 77% identical and 94% homol-
ogous. Class I proteins are widespread and are found in both
unicellular and multicellular eukaryotes but not bacteria.
Examples of such multicellular eukaryotes include mammals
(humans, mice, rat, rabbit), £ies (Drosophila melanogaster,
Anopheles gambiae), worms (Caenorhabditis elegans) and ¢sh
(Danio rerio (zebra¢sh) and Fugu rubripes (Japanese pu¡er
¢sh)). Examples of simple unicellular eukaryotes which con-
tain proteins which are similar in size and sequence to PITPK/
L and contain a single PITP domain include parasites (Plas-
modium falciparum, Encephalitozoon cuniculi) and soil amoe-
bae (Dictyostelium discoideum). E. cuniculi is an interesting
parasite as its genome is compact meaning that many of the
proteins are shortened compared to their counterparts in oth-
er organisms [19]. Thus the PITP protein is only 251 amino
acids long compared to 270 in humans and has lost residues at
the C-terminus. In PITPK, the C-terminus is important for
maintaining the structure in a compact form (see later). How-
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ever, since the C-terminal region is the most divergent be-
tween PITPK and PITPL, the protein may have a di¡erent
strategy to maintain its compact structure.
Class II PITPs are the RdgB proteins, so named because
the ¢rst isoform was identi¢ed in Drosophila as the gene re-
sponsible for degeneration of the retina (retinal degeneration
mutant phenotype type B). RdgB proteins are classi¢ed into
Class IIA (RdgBK) and IIB (RdgBL) which is based on their
size. RdgBK proteins are 160 kDa and possess an N-terminal
PITP domain followed by an acidic calcium binding domain,
six short hydrophobic regions, a putative metal ion binding
domain and a carboxy-terminal PYK2 binding domain.
Whilst Drosophila and C. elegans have a single RdgBK gene,
mice/humans have two genes (m-RdgBKI and m-RdgBKII). In
Drosophila RdgBK is required for both photoreceptor cell vi-
ability and the light response. Mammalian RdgBKI has wide-
spread tissue distribution and can functionally rescue the Dro-
sophila RdgB mutant phenotypes. RdgBKII possesses a
neuronal-speci¢c expression pattern, with high levels in the
retina and the dentate gyrus of the hippocampus. RdgBKII
cannot fully restore the light response in Drosophila, unlike
RdgBKI, indicating that functional di¡erences are likely to
exist between the two mammalian RdgB homologues [20].
More recently, a 38 kDa soluble form of PITP was cloned
which was more closely related in sequence to the PITP do-
main of RdgBK, and termed RdgBL which forms Class IIB
[21] (Table 1). RdgBL is widely expressed in most tissues in-
cluding heart, muscle, kidney, liver and peripheral blood leu-
kocytes.
In the yeast S. cerevisiae, a 35 kDa protein has been char-
acterised as a PITP (Sec14p) but bears no sequence or struc-
tural homology to Class I and Class II PITPs [15]. To distin-
guish between Class I and II PITPs and yeast PITPs (Sec14p),
we will refer to this family of proteins as Class III proteins
which includes Sec14p and other sequence-related proteins.
Sec14p is localised to the Golgi and is essential for protein
transport from the Golgi complex [22]. Most relevant to the
discussion here is that the temperature-sensitive mutants (but
not null) can be rescued by over-expression of either PITPK or
PITPL [23,24]. Sec14p-related proteins are widespread and are
found in humans, mice, plants and many forms of yeast. Not
all Sec14p-related proteins are PITPs, however; some bind
and transfer other hydrophobic ligands such as K-tocopherol,
11-cis-retinal and squalene [25,26]. Also the biological func-
tion of Sec14p is di¡erent in various yeasts. In Yarrowia lipo-
lytica, Sec14p is not required for viability nor for the secretory
pathway but is required for dimorphic transition from the
yeast to the mycelial form that typi¢es this species [27]. In
Schizosaccharomyces pombe, Sec14p is required for both se-
cretory function and forespore membrane formation [28]. De-
spite the di¡erent biological functions ascribed to Sec14p, it is
probable that the underlying core biochemistry is the same.
Thus lessons can be learnt from Sec14p studies in yeast. The
Sec14p from S. cerevisiae has been subject of much investiga-
tion and the available genetic and biochemical data indicate
that Sec14p modulates both PI and PC metabolism. Sec14p
regulates the levels of PI 4-phosphate at the Golgi [29,30] and
also levels of diacylglycerol (DAG) by inhibiting its utilisation
for PC synthesis [31]. In this brief review, the Sec14p family of
PITPs will be mentioned where pertinent in understanding the
Class I PITPs. In particular this is most relevant for PITPL,
which, like Sec14p, is also Golgi-localised [32,33].
3. What gene knockout studies tell us about biological function
In mice, the essential nature of PITP is indicated by the
vibrator mutation, which causes neuronal degeneration due
to a ¢vefold reduction in PITPK levels [34]. The vibrator mu-
tation causes an early-onset progressive action tremor, degen-
eration of brainstem and spinal cord neurones, followed by
juvenile death. Further support for an in vivo role in neuronal
function comes from the characterisation of Drosophila rdgB
mutations where the null mutants undergo light-induced ret-
inal degeneration. The Drosophila RdgB protein is a mem-
brane-associated protein containing a PITP domain. In this
organism, RdgBK functions together with rhodopsin, Gq-re-
lated G protein and a phospholipase CL isozyme in the visual
signal transduction cascade [35,36]. In contrast, deletion of the
gene encoding mouse PITPL or RdgBKI is embryonic lethal
[37,38]. In C. elegans, RNAi has been used to knock out two
of the three PITP genes individually but no phenotype was
recorded. The presence of ¢ve proteins with a PITP domain in
Table 1
Classi¢cation of the proteins containing the PITP domain from various organisms
Organism Proteins with PITP domains Comments
Class I Class IIA Class IIB
Homo sapiens/Mus musculus PITPK (vibrator) RdgBKI/Nir2/
PITPnm
RdgBL PITPK ^ vibrator phenotype
PITPL RdgBKII/Nir3 PITPL ^ embryonic lethal
RdgBKI ^ embryonic lethal
RdgBKII ^ no obvious phenotype
Caenorhabditis elegans PITP1 RdgBK Not present RNAi knockout of PITP1 and RdgBK
PITP2 No obvious phenotype
Drosophila PITP (vib) RdgBK RdgBL RdgBK ^ retinal degeneration
Dictyostelium PITP I Not identi¢ed Not identi¢ed Dd-Sec14p is also found in this organism which is
a bona ¢de PITP
PITP II
Plasmodium falciparum PITP Not identi¢ed Not identi¢ed Malarial parasite
Encephalitozoon cuniculi PITP Not present Not present Eukaryotic unicellular parasite containing 1997
potential protein coding genes only
Saccharomyces cerevisiae Not present Not present Not present Yeast PITP (Sec14p)
Schizosaccharomyces pombe Not present Not present Not present Yeast PITP (Sec14p)
The sequence-unrelated yeast PITPs (Sec14p family) are not classi¢ed in the table. Sec14p and Sec14p-related proteins are widespread in mam-
mals, plants and yeasts (designated Class III) (see text).
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mammalian cells and their widespread expression supports the
emerging concept that di¡erent PITP proteins have distinct
functions in vivo. Whilst there is much evidence supporting
an important role of PITPs in neuronal function in both £ies
and mammals, the presence of PITP genes in unicellular or-
ganisms, including parasites, indicates that PITP proteins
have been put to use in multiple ways. The underlying core
biochemical mechanism is, however, likely to be the same ^ its
ability to regulate lipid metabolism. Knockout studies in these
di¡erent organisms will be required to reveal the multitude of
biological functions of this family of proteins.
4. Coupling the ability to transport lipids to their subsequent
metabolism
The emergent view is that PITP proteins are not just passive
mediators of lipid transport but function in complex ways by
modulating phospholipid metabolic pathways and impacting
on many cellular processes including lipid-mediated signalling
pathways and membrane tra⁄c. Studies from permeabilised
cells indicate that PITP is an integral part of the machinery
which is required for the receptor-regulated production of the
two second messengers, inositol 1,4,5-trisphosphate and DAG
by phospholipase Cs (PLCs) [5,6,39] and for phosphoinositide
3-kinase-mediated phosphatidylinositol 3,4,5-trisphosphate
(PI(3,4,5)P3) production [9]. The PLC signalling pathway is
a major consumer of phosphatidylinositol 4,5-bisphosphate
(PI(4,5)P2) and the plasma membrane pool of inositol lipids
is replenished with PI from intracellular compartments by
PITP, by virtue of its ability to bind and deliver PI [39,40].
PITP also participates in the subsequent phosphorylation of
PI [6,8]. Thus PITP couples PI delivery and PI(4,5)P2 syn-
thesis in cell signalling. In membrane transport, PITP plays
a role in the provision of PI for further phosphorylation. In
particular, PITP can in£uence the production of 3-phosphor-
ylated phosphoinositides including phosphatidylinositol
3-phosphate [7,10,41]. The intact phosphorylated inositol lipid
then provides a binding site for cytosolic proteins to be re-
cruited to membrane surfaces where they can mediate their
biological functions [42].
PITPL, in addition to transferring PI and PC, has been
reported to transfer sphingomyelin (SM) [32,43]. In these
studies PITPL was reported to exhibit a higher transfer activ-
ity towards £uorescent SM than even PI, suggesting that
PITPL bound SM with high a⁄nity. However, in two recent
studies, transfer was examined using natural cellular SM, and
it was concluded that both PITPK and PITPL were capable of
transferring SM with a low but comparable e⁄ciency, and
that PITP transfer activity towards SM was much less com-
pared to that towards PI and PC. PITPL was found to be
marginally better than PITPK in transferring SM in both these
studies [33,44]. Previous studies where £uorescent SM was
used may be misleading due to the presence of the bulky
£uorophore, which could a¡ect both packing of the donor
membrane and the binding of the lipid to the PITP. Thus
the SM transfer function of PITPL in SM signalling and traf-
¢c remains unclear.
Studies from S. cerevisiae have indicated that Sec14p is
important for regulating PC metabolism and ensuring that
DAG is available at the Golgi for vesicle formation [45].
These studies have prompted the examination of the possible
role of PITPL and PITPK in modulating PC metabolism. In
addition, because PITPL was reported to transport SM (as
discussed above), the possible role of PITPL in SM metabo-
lism has been also examined. In mammalian cells, the syn-
thesis of PC and SM are localised in the endoplasmic retic-
ulum (ER) and Golgi respectively (Fig. 1). In three separate
studies, the role of PITP in the metabolism of PI and PC has
been examined. In the ¢rst study, antisense RNA was used to
reduce the amount of PITPK by 25% in WRK-1 rat mammary
tumour cells. This resulted in a 30^40% decrease in choline
metabolites including PC, SM, lyso-PC, glycerophosphocho-
line and choline whilst cholineP and CDP-choline were in-
creased. The results were interpreted to mean that the rate-
limiting enzyme, phosphorylcholine cytidyl transferase, was
inhibited (see Fig. 1). Thus the decrease in PC de novo syn-
thesis observed here [46] is in contrast to the situation in yeast
where suppression of Sec14p leads to enhanced PC synthesis
[47]. No e¡ects were observed on inositol-derived lipids before
and subsequent to stimulation with vasopressin. However, a
25% decrease in PITPK may not be su⁄cient to show any
e¡ects as both PITPK and PITPL are able to replenish PI to
the plasma membrane (see later).
In a second study, PITPL over-expression (over 10-fold) in
NIH3T3 cells was shown to enhance re-synthesis of SM upon
degradation by exogenous sphingomyelinase (SMase). The re-
sults were interpreted to mean that PITPL regulated SM syn-
thase activity and/or SM transport from the Golgi to the
plasma membrane [48] (see Fig. 1). SM synthesis mainly oc-
curs in the lumen of the Golgi from which it is transported to
the outer lea£et of the plasma membrane by vesicular tra⁄c.
SM synthase transfers the phosphocholine moiety of PC to
ceramide in order to generate SM and DAG [49]. Therefore,
SM synthase may contribute to the reciprocal regulation of
the levels of PC and DAG in Golgi membranes (see Fig. 1).
In the third study, we have examined whether over-expres-
sion of PITPK or PITPL modulates sphingolipid and PC me-
tabolism [50]. Using COS-7 cells, PITPL over-expression did
not stimulate SM re-synthesis upon degradation by exogenous
SMase, suggesting that the ability of PITPL to interfere with
SM metabolism might be cell type-speci¢c. On the other hand,
the amount of endogenous PITPL in COS-7 cells might be
su⁄cient for stimulating SM synthase activity. Nevertheless,
in puri¢ed Golgi membranes that are depleted in endogenous
PITPL, the addition of recombinant PITPL does not increase
SM production (but increases phosphatidylinositol 4-phos-
phate production (D. Jones and S. Cockcroft, unpublished)).
Additionally, over-expression of either PITP did not a¡ect de
novo PC synthesis [50].
The conclusions drawn from studies where PITPs have been
over-expressed or suppressed are inconsistent with each other
and further work needs to be done.
5. Mechanism of lipid exchange
How do lipid transfer proteins exchange their cargo lipid?
This is a common problem shared by all lipid transport pro-
teins as the proteins have to be soluble but must transiently
associate with the membrane in order to pick up their hydro-
phobic ligand. Another common property shared by PITP
and other lipid transporters is that the ligand is in a binding
pocket and the protein has to undergo a conformational
change to open this cavity in order to allow the lipid to leave.
What determines this process is critical in our understanding
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of how these proteins can ful¢l their functions. The structures
of PITPK complexed with PC and the apo-PITPK have been
solved by X-ray crystallography [13,51] and provide a mech-
anistic insight into this process. PITPK is characterised by an
eight-stranded, concave L-sheet £anked by two long K-helices,
which de¢ne an enclosed internal cavity in which a single
molecule of PC is accommodated [13]. The polar headgroup
lies in the centre of the protein with the fatty acyl chains
projecting towards the surface (see Fig. 2A).
The structure of the apo-form, together with extensive bio-
chemical analysis of C-terminal deletion mutants, provides the
possibility of constructing events that could allow the protein
to open its cavity thus allowing the lipid to depart (see Fig.
2B). At its C-terminus, PITPK has an K-helix (G-helix) fol-
lowed by an extension of 11 amino acids [13]. Prior to any
knowledge of the structure, limited proteolysis was used to
obtain structural insights. The protease subtilisin removed
24 amino acids from the C-terminus (see Fig. 2A) and this
led to the dimerisation of the truncated PITP molecule accom-
panied by loss of transfer function, as well as the ability to
reconstitute PLC signalling [52] (PLC signalling provides a
measure of both PI transfer and phosphoinositide synthesis
Fig. 1. An outline of the metabolic pathways to PC, SM and GluCer synthesis that have been examined following over-expression and suppres-
sion of PITPK and PITL (see text for further details). Based on the study by Monaco et al. [46], a decrease in PITPK leads to partial inhibition
of PC synthesis and the site for its action is shown. Two separate studies have examined the e¡ects of over-expression of PITPL (which local-
ises at the Golgi) on sphingolipid metabolism. In a study using NIH 3T3 ¢broblasts, hydrolysis of SM at the external lea£et of the plasma
membrane by exogenous SMase, led to enhanced replenishment of SM at the plasma membrane [48]. In a second study using COS-7 cells, no
changes in replenishment was observed [33].
Fig. 2. Comparison of the PITP structure loaded with PC and without the lipid. The structures were made in Rasmol from the following PDB
codes, (A) 1FVZ and (B) 1KCM. The L-sheets are in yellow and K-helices are in red. The PC molecule in the structure is in green. The C-ter-
minus indicated in A wraps in the lipid whilst in the structure in B the G-helix has swung out exposing the lipid fatty acyl chains towards the
membrane. The site of cleavage by subtilisin at Met246, which removes 24 amino acids, is indicated. The position of the membrane in relation-
ship to the PITP molecule is indicated for the apo-structure (B).
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examined in permeabilised cells [5,39]). A systematic deletion
of the C-terminus of ¢ve, 10 and 20 amino acids indicated
that deletion of only ¢ve amino acids is su⁄cient to impair the
ability of PITPK to function in the reconstitution of PLC
signalling [53]. Nonetheless, the protein retained its ability
to bind its lipid although its transfer activity was reduced.
Limited protease digestion with trypsin only occurs in the
presence of lipid vesicles and, in this case, the PITPK is
cleaved to give two products, one lacking 12 amino acids
and the other lacking 18 amino acids [54]. These C-terminal
truncated proteins have a more relaxed conformation and
show a higher a⁄nity for membranes compared to the full
length protein, which could explain the decrease in transfer
activity [54^56]. Although membrane binding is a necessary
condition of lipid transfer, if the association is too strong the
protein will be immobilised and therefore unable to partici-
pate in multiple rounds of transfer. Thus, the C-terminus is
critical in ensuring that the PITPK molecule has a compact
structure and remains soluble. Movement of the C-terminus
appears to be required to expose a hydrophobic surface (hence
dimerisation of both the apo-structure and the deletion mu-
tants) that would allow the protein to interact with the mem-
brane. The apo-structure provides a snapshot of this process
where the G K-helix and the C-terminal 11 amino acids have
moved, exposing the lipid binding cavity [51] (see Fig. 2B). In
this open state, a channel is created for the lipid to depart and
key hydrophobic residues are exposed which can interact with
the membrane, possibly including insertion into the mem-
brane. Mutational analysis of the hydrophobic amino acids
are now essential to con¢rm this model.
6. Is lipid transfer a regulated process?
Living cells maintain the identity of their organelles with
respect to their lipid and protein composition in the face of
ongoing tra⁄c between these compartments. Despite the pres-
ence of uniformly high concentrations of PITPK or PITPL
(dependent on cell type) in the cytosol, the concentration of
PI is not identical in the di¡erent organelles. There is a gra-
dient of PI as one moves through the secretory pathway, the
highest concentration at the ER followed by the Golgi and
¢nally the plasma membrane.
So what can regulate the lipid transfer process? Since the
lipid transport proteins have to dock to the membrane to
exchange their cargo ligand, the key must lie either in the
structure of the membrane or in a signal-induced change in
the conformation of PITPK. A change in the membrane could
occur when cells are actively consuming PI(4,5)P2 by PLC
hydrolysis or phosphorylation to PI(3,4,5)P3, and this may
cause local deformations in membrane structure. Thus, a pos-
sible scenario is that these transfer proteins constantly bump
into a membrane, but do not open their hydrophobic pocket
unless the membrane is perturbed in some way such that the
local packing density of the lipids is disrupted. Under these
conditions, the PITP molecules may accumulate at sites of
perturbation, permitting the opening of the cavity and exit
of the lipid. Binding of a lipid to the apo-PITP may then
drive the cavity to close and the protein to move o¡ the
membrane.
The presence of a PITP domain in proteins, which are al-
ready membrane-associated, raises the question of other func-
tions of these domains, in addition to lipid transfer. One
common role for lipid binding motifs such as PH domains,
FYVE domains, C1 domains, C2 domains and PX domains,
which are widely distributed domains, appears to be in the
targeting of proteins to speci¢c subcellular compartments [57].
In these cases the lipid headgroups bind speci¢cally to a pock-
et or groove on the protein surface, tethering the protein to
the membrane. These structures are designed to recognise
speci¢c lipids embedded in lipid bilayers only. Since the
PITP domain actually binds the monomeric lipid, the poten-
tial function of these proteins must be rather di¡erent. In
principle, the PITP domain can switch between the PC- or
PI-bound form and conceivably this may function as a mo-
lecular switch, similar to G proteins, which switch between the
active GTP-bound form and the inactive GDP-bound form.
This requires that the structures of the PC-bound and PI-
bound forms of PITP are distinct if they are to function as
molecular switches. Recent studies have shown that the PC-
bound form of PITPK is a better substrate for protein kinase
C-mediated phosphorylation at serine 166 compared with the
PI-bound form of PITPK [58]. This suggests that the two
forms of PITPK are structurally di¡erent. The availability of
the structure of the PI-bound form of PITP is eagerly awaited,
as this will provide substance to this idea.
In vitro, PITP proteins have constitutive transfer activity,
not dissimilar to the case of PLCs when they are assayed in
vitro. In intact cells, the transfer activity of PITPs has not
been assessed so far. We have begun to examine whether
PITP proteins can be regulated by cell surface receptors.
One way to examine interactions of PITP when it goes to a
membrane to pick a lipid is to use £uorescence resonance
energy transfer (FRET). FRET is only observed when mole-
cules are in close proximity (6 10 nm), and therefore are able
to transfer energy from the donor to the acceptor. We have
monitored FRET between compatible £uorophores, green
£uorescent protein (GFP) and BODIPY, attached to PITP
and lipids respectively, in the presence and absence of epider-
mal growth factor [59]. In unstimulated cells, BODIPY PI or
PC were not in close enough proximity to GFP-PITPK, and
no FRET was observed. However, upon stimulation, FRET is
observed at the plasma membrane indicating an accumulation
of PITPK (or PITPL) molecules bound with BODIPY-labelled
PI or PC. FRET is not observed when BODIPY-PE is used
indicating that this interaction is speci¢c for PITP ligands, PI
and PC, and one is not simply monitoring the association of
PITP with a membrane. From these studies, it becomes ap-
parent that the lipid transfer activity of the protein is regu-
lated in vivo. We can now address the question of what pro-
motes the accumulation of PITP proteins to the plasma
membrane following stimulation.
7. The way forward
PITP proteins have come a long way since their discovery in
the early 1970s as lipid transporters. Whilst much of the early
thinking has been driven by this biochemical activity, it is now
clear that these proteins play more complex roles, of which
the transport function is only one. From studies where cyto-
solic proteins have been removed from cells by permeabilisa-
tion, PITP proteins have been found to reconstitute many
aspects of signal transduction and vesicular tra⁄c including
exocytosis [1,3]. The major limitation of these studies is the
insult that the cells undergo in such reconstitution studies. To
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examine PITP function in intact cells, the available options
have been to over-express PITP, to decrease the PITP concen-
trations using antisense technology, or to generate dominant
negative mutants. We and others have applied these methods
with only limited success [33,46,48,53]. We have attempted to
generate dominant negative mutants to study PITP function
in intact cells, but have not succeeded so far and this is most
likely because PITP proteins may not directly associate with
other proteins but with membrane lipids only. Over-expres-
sion does not result in any obvious phenotype and suppres-
sion of endogenous protein requires cell selection over a long
period, which makes comparisons between two cell popula-
tions di⁄cult.
There is light at the end of the tunnel with recent advances
in RNAi technology that can be applied to mammalian cells
in culture. We are currently engaged in using this approach to
examine whether these proteins really play roles in membrane
turnover and in signal transduction. Structural studies are in
progress; we shall soon have the structure of the PI-liganded
PITP and with this information, it will be possible to design
PITPs that can only bind and transfer PI or PC. The use of
RNAi coupled with PITP mutants selective for PI or PC
transfer will provide insights into PITP function in intact liv-
ing cells. Exciting times lie ahead for unravelling the biolog-
ical functions of this family of enigmatic proteins and this will
require the further development of new technologies to study
membrane lipid/protein dynamics in living cells.
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